119 related articles for article (PubMed ID: 10395107)
1. A new beta 2 microglobulin mutation found in a melanoma tumor cell line.
Pérez B; Benitez R; Fernández MA; Oliva MR; Soto JL; Serrano S; López Nevot MA; Garrido F
Tissue Antigens; 1999 Jun; 53(6):569-72. PubMed ID: 10395107
[TBL] [Abstract][Full Text] [Related]
2. beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
Hicklin DJ; Wang Z; Arienti F; Rivoltini L; Parmiani G; Ferrone S
J Clin Invest; 1998 Jun; 101(12):2720-9. PubMed ID: 9637706
[TBL] [Abstract][Full Text] [Related]
3. Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors.
Fernández MA; Ruiz-Cabello F; Oliva MR; Cabrera T; Jimenez P; López Nevot MA; Garrido F
Int J Clin Lab Res; 2000; 30(2):87-92. PubMed ID: 11043502
[TBL] [Abstract][Full Text] [Related]
4. Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.
Wang Z; Cao Y; Albino AP; Zeff RA; Houghton A; Ferrone S
J Clin Invest; 1993 Feb; 91(2):684-92. PubMed ID: 8432869
[TBL] [Abstract][Full Text] [Related]
5. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
[TBL] [Abstract][Full Text] [Related]
6. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.
Benitez R; Godelaine D; Lopez-Nevot MA; Brasseur F; Jiménez P; Marchand M; Oliva MR; van Baren N; Cabrera T; Andry G; Landry C; Ruiz-Cabello F; Boon T; Garrido F
Tissue Antigens; 1998 Dec; 52(6):520-9. PubMed ID: 9894850
[TBL] [Abstract][Full Text] [Related]
8. Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance.
Hicklin DJ; Dellaratta DV; Kishore R; Liang B; Kageshita T; Ferrone S
Melanoma Res; 1997 Aug; 7 Suppl 2():S67-74. PubMed ID: 9578419
[TBL] [Abstract][Full Text] [Related]
9. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
[TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface.
Gattoni-Celli S; Kirsch K; Timpane R; Isselbacher KJ
Cancer Res; 1992 Mar; 52(5):1201-4. PubMed ID: 1737380
[TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.
Bicknell DC; Rowan A; Bodmer WF
Proc Natl Acad Sci U S A; 1994 May; 91(11):4751-5. PubMed ID: 8197130
[TBL] [Abstract][Full Text] [Related]
13. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.
Hsieh CH; Hsu YJ; Chang CC; Liu HC; Chuang KL; Chuang CK; Pang ST; Hasumi K; Ferrone S; Liao SK
Cancer Immunol Immunother; 2009 Mar; 58(3):395-408. PubMed ID: 18704411
[TBL] [Abstract][Full Text] [Related]
14. Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.
Bernal M; Ruiz-Cabello F; Concha A; Paschen A; Garrido F
Cancer Immunol Immunother; 2012 Sep; 61(9):1359-71. PubMed ID: 22833104
[TBL] [Abstract][Full Text] [Related]
15. Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.
Jordanova ES; Riemersma SA; Philippo K; Schuuring E; Kluin PM
Int J Cancer; 2003 Jan; 103(3):393-8. PubMed ID: 12471623
[TBL] [Abstract][Full Text] [Related]
16. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
Wang Z; Arienti F; Parmiani G; Ferrone S
Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer.
Chen HL; Gabrilovich D; Virmani A; Ratnani I; Girgis KR; Nadaf-Rahrov S; Fernandez-Viña M; Carbone DP
Int J Cancer; 1996 Sep; 67(6):756-63. PubMed ID: 8824545
[TBL] [Abstract][Full Text] [Related]
18. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
20. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
